← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Colby Pharmaceutical Company
Menlo Park, CA
$3,598,305
Total funding
4
Grants
Funding over time
peak $1.5M · FY2008–14$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$3,598,305 · 4
By mechanism
N43$1,749,975 · 1
U01$1,438,772 · 1
R43$409,558 · 2
Investigators at Colby Pharmaceutical Company
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
IGF::OT::IGF R&D- MEDICAL: BIOMEDICAL (BASIC RESEARCH) A NOVEL AGENT THAT REDUCE$1,499,978
N01 · FY2014 · CA
Adjuvant Enhanced Antiviral Immunity$1,438,772
U01 · FY2011 · AI
Androgen Receptor-JunD Complex Inhibitors to Prevent Prostate Cancer Progression$300,000
R43 · FY2012 · CA
IGF::OT::IGF R&D- MEDICAL: BIOMEDICAL (BASIC RESEARCH) A NOVEL AGENT THAT REDUCE$249,997
N43 · FY2013 · CA
Mitochondria Targeted Anti-oxidant for Treatment of Prostate Cancer$109,558
R43 · FY2008 · CA